APO Research
Talk to an analyst

APO RESEARCH · REPORT

Psychiatric API

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Psychiatric API Industry Growth and Trends Forecast to 2032

22 December 2025110 pages

Choose your research edition.

Industry ResearchPsychiatric API Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Psychiatric API Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Psychiatric API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Psychiatric API Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Psychiatric API Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global Psychiatric API market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Psychiatric API is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Psychiatric API is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Psychiatric API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Psychiatric API include Yaopharma, Yangtze River Pharmaceutical, Sichuan Chuanda West China Pharmaceutical, Ren An Pharmaceutical, Eli Lilly, Kanghong Pharmaceutical, Pfizer, Huahai Pharmaceutical and Hengrui Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Psychiatric API market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Psychiatric API market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Psychiatric API market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Psychiatric API.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Psychiatric API market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Psychiatric API Market by Company

Yaopharma

Yangtze River Pharmaceutical

Sichuan Chuanda West China Pharmaceutical

Ren An Pharmaceutical

Eli Lilly

Kanghong Pharmaceutical

Pfizer

Huahai Pharmaceutical

Hengrui Pharmaceuticals

Herui Pharmaceutical

Dongting Pharmaceutical

Brilliant Pharmaceutical

Salutas Pharma

Germany Pharmaceutical

Dr.Reddy's Laboratories

Bora Pharmaceutical

Psychiatric API Segment by Type

Venlafaxine

Paroxetine

Duloxetine

Olanzapine

Others

Psychiatric API Segment by Application

Generalized Anxiety Disorder

Schizophrenia

Fibromyalgia

Major Depressive Disorder

Others

Psychiatric API Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Psychiatric API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Psychiatric API and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Psychiatric API.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Psychiatric API manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Psychiatric API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Venlafaxine Table 2. Major Company of Paroxetine Table 3. Major Company of Duloxetine Table 4. Major Company of Olanzapine Table 5. Major Company of Others Table 6. Global Psychiatric API Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Psychiatric API Sales by Type (2021-2026) & (k units) Table 8. Global Psychiatric API Sales Market Share in Volume by Type (2021-2026) Table 9. Global Psychiatric API Sales by Type (2021-2026) & (US$ Million) Table 10. Global Psychiatric API Sales Market Share in Value by Type (2021-2026) Table 11. Global Psychiatric API Price by Type (2021-2026) & (US$/unit) Table 12. Global Psychiatric API Sales by Type (2027-2032) & (k units) Table 13. Global Psychiatric API Sales Market Share in Volume by Type (2027-2032) Table 14. Global Psychiatric API Sales by Type (2027-2032) & (US$ Million) Table 15. Global Psychiatric API Sales Market Share in Value by Type (2027-2032) Table 16. Global Psychiatric API Price by Type (2027-2032) & (US$/unit) Table 17. North America Psychiatric API Sales by Type (2021-2026) & (k units) Table 18. North America Psychiatric API Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Psychiatric API Sales by Type (2021-2026) & (k units) Table 20. Europe Psychiatric API Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Psychiatric API Sales by Type (2021-2026) & (k units) Table 22. Asia-Pacific Psychiatric API Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Psychiatric API Sales by Type (2021-2026) & (k units) Table 24. Latin America Psychiatric API Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Psychiatric API Sales by Type (2021-2026) & (k units) Table 26. Middle East and Africa Psychiatric API Sales by Type (2021-2026) & (US$ Million) Table 27. Psychiatric API Industry Trends Table 28. Psychiatric API Industry Drivers Table 29. Psychiatric API Industry Opportunities and Challenges Table 30. Psychiatric API Industry Restraints Table 31. Global Psychiatric API Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Psychiatric API Revenue Market Share by Company (2021-2026) Table 33. Global Psychiatric API Sales by Company (2021-2026) & (k units) Table 34. Global Psychiatric API Sales Share by Company (2021-2026) Table 35. Global Psychiatric API Market Price by Company (2021-2026) & (US$/unit) Table 36. Global Psychiatric API Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Psychiatric API Major Company Production Sites and Headquarters Table 38. Global Psychiatric API Company, Product Type & Application Table 39. Global Psychiatric API Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Psychiatric API by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Psychiatric API Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Psychiatric API Sales by Region (2021-2026) & (k units) Table 44. Global Psychiatric API Sales Market Share in Volume by Region (2021-2026) Table 45. Global Psychiatric API Sales by Region (2021-2026) & (US$ Million) Table 46. Global Psychiatric API Sales Market Share in Value by Region (2021-2026) Table 47. Global Psychiatric API Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 48. Global Psychiatric API Sales by Region (2027-2032) & (k units) Table 49. Global Psychiatric API Sales Market Share in Volume by Region (2027-2032) Table 50. Global Psychiatric API Sales by Region (2027-2032) & (US$ Million) Table 51. Global Psychiatric API Sales Market Share in Value by Region (2027-2032) Table 52. Global Psychiatric API Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 53. Global Psychiatric API Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Psychiatric API Sales by Application (2021-2026) & (k units) Table 55. Global Psychiatric API Sales Market Share in Volume by Application (2021-2026) Table 56. Global Psychiatric API Sales by Application (2021-2026) & (US$ Million) Table 57. Global Psychiatric API Sales Market Share in Value by Application (2021-2026) Table 58. Global Psychiatric API Price by Application (2021-2026) & (US$/unit) Table 59. Global Psychiatric API Sales by Application (2027-2032) & (k units) Table 60. Global Psychiatric API Sales Market Share in Volume by Application (2027-2032) Table 61. Global Psychiatric API Sales by Application (2027-2032) & (US$ Million) Table 62. Global Psychiatric API Sales Market Share in Value by Application (2027-2032) Table 63. Global Psychiatric API Price by Application (2027-2032) & (US$/unit) Table 64. North America Psychiatric API Sales by Application (2021-2026) & (k units) Table 65. North America Psychiatric API Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Psychiatric API Sales by Application (2021-2026) & (k units) Table 67. Europe Psychiatric API Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Psychiatric API Sales by Application (2021-2026) & (k units) Table 69. Asia-Pacific Psychiatric API Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Psychiatric API Sales by Application (2021-2026) & (k units) Table 71. Latin America Psychiatric API Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Psychiatric API Sales by Application (2021-2026) & (k units) Table 73. Middle East and Africa Psychiatric API Sales by Application (2021-2026) & (US$ Million) Table 74. Yaopharma Company Information Table 75. Yaopharma Business Overview Table 76. Yaopharma Psychiatric API Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. Yaopharma Psychiatric API Product Portfolio Table 78. Yaopharma Recent Development Table 79. Yangtze River Pharmaceutical Company Information Table 80. Yangtze River Pharmaceutical Business Overview Table 81. Yangtze River Pharmaceutical Psychiatric API Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. Yangtze River Pharmaceutical Psychiatric API Product Portfolio Table 83. Yangtze River Pharmaceutical Recent Development Table 84. Sichuan Chuanda West China Pharmaceutical Company Information Table 85. Sichuan Chuanda West China Pharmaceutical Business Overview Table 86. Sichuan Chuanda West China Pharmaceutical Psychiatric API Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. Sichuan Chuanda West China Pharmaceutical Psychiatric API Product Portfolio Table 88. Sichuan Chuanda West China Pharmaceutical Recent Development Table 89. Ren An Pharmaceutical Company Information Table 90. Ren An Pharmaceutical Business Overview Table 91. Ren An Pharmaceutical Psychiatric API Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. Ren An Pharmaceutical Psychiatric API Product Portfolio Table 93. Ren An Pharmaceutical Recent Development Table 94. Eli Lilly Company Information Table 95. Eli Lilly Business Overview Table 96. Eli Lilly Psychiatric API Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. Eli Lilly Psychiatric API Product Portfolio Table 98. Eli Lilly Recent Development Table 99. Kanghong Pharmaceutical Company Information Table 100. Kanghong Pharmaceutical Business Overview Table 101. Kanghong Pharmaceutical Psychiatric API Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 102. Kanghong Pharmaceutical Psychiatric API Product Portfolio Table 103. Kanghong Pharmaceutical Recent Development Table 104. Pfizer Company Information Table 105. Pfizer Business Overview Table 106. Pfizer Psychiatric API Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 107. Pfizer Psychiatric API Product Portfolio Table 108. Pfizer Recent Development Table 109. Huahai Pharmaceutical Company Information Table 110. Huahai Pharmaceutical Business Overview Table 111. Huahai Pharmaceutical Psychiatric API Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 112. Huahai Pharmaceutical Psychiatric API Product Portfolio Table 113. Huahai Pharmaceutical Recent Development Table 114. Hengrui Pharmaceuticals Company Information Table 115. Hengrui Pharmaceuticals Business Overview Table 116. Hengrui Pharmaceuticals Psychiatric API Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 117. Hengrui Pharmaceuticals Psychiatric API Product Portfolio Table 118. Hengrui Pharmaceuticals Recent Development Table 119. Herui Pharmaceutical Company Information Table 120. Herui Pharmaceutical Business Overview Table 121. Herui Pharmaceutical Psychiatric API Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 122. Herui Pharmaceutical Psychiatric API Product Portfolio Table 123. Herui Pharmaceutical Recent Development Table 124. Dongting Pharmaceutical Company Information Table 125. Dongting Pharmaceutical Business Overview Table 126. Dongting Pharmaceutical Psychiatric API Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 127. Dongting Pharmaceutical Psychiatric API Product Portfolio Table 128. Dongting Pharmaceutical Recent Development Table 129. Brilliant Pharmaceutical Company Information Table 130. Brilliant Pharmaceutical Business Overview Table 131. Brilliant Pharmaceutical Psychiatric API Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 132. Brilliant Pharmaceutical Psychiatric API Product Portfolio Table 133. Brilliant Pharmaceutical Recent Development Table 134. Salutas Pharma Company Information Table 135. Salutas Pharma Business Overview Table 136. Salutas Pharma Psychiatric API Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 137. Salutas Pharma Psychiatric API Product Portfolio Table 138. Salutas Pharma Recent Development Table 139. Germany Pharmaceutical Company Information Table 140. Germany Pharmaceutical Business Overview Table 141. Germany Pharmaceutical Psychiatric API Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 142. Germany Pharmaceutical Psychiatric API Product Portfolio Table 143. Germany Pharmaceutical Recent Development Table 144. Dr.Reddy's Laboratories Company Information Table 145. Dr.Reddy's Laboratories Business Overview Table 146. Dr.Reddy's Laboratories Psychiatric API Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 147. Dr.Reddy's Laboratories Psychiatric API Product Portfolio Table 148. Dr.Reddy's Laboratories Recent Development Table 149. Bora Pharmaceutical Company Information Table 150. Bora Pharmaceutical Business Overview Table 151. Bora Pharmaceutical Psychiatric API Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 152. Bora Pharmaceutical Psychiatric API Product Portfolio Table 153. Bora Pharmaceutical Recent Development Table 154. North America Psychiatric API Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 155. North America Psychiatric API Sales by Country (2021-2026) & (k units) Table 156. North America Psychiatric API Sales Market Share by Country (2021-2026) Table 157. North America Psychiatric API Sales Forecast by Country (2027-2032) & (k units) Table 158. North America Psychiatric API Sales Market Share Forecast by Country (2027-2032) Table 159. North America Psychiatric API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 160. North America Psychiatric API Market Size by Country (2021-2026) & (US$ Million) Table 161. North America Psychiatric API Market Share by Country (2021-2026) Table 162. North America Psychiatric API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 163. North America Psychiatric API Market Share Forecast by Country (2027-2032) Table 164. Europe Psychiatric API Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 165. Europe Psychiatric API Sales by Country (2021-2026) & (k units) Table 166. Europe Psychiatric API Sales Market Share by Country (2021-2026) Table 167. Europe Psychiatric API Sales Forecast by Country (2027-2032) & (k units) Table 168. Europe Psychiatric API Sales Market Share Forecast by Country (2027-2032) Table 169. Europe Psychiatric API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 170. Europe Psychiatric API Market Size by Country (2021-2026) & (US$ Million) Table 171. Europe Psychiatric API Market Share by Country (2021-2026) Table 172. Europe Psychiatric API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 173. Europe Psychiatric API Market Share Forecast by Country (2027-2032) Table 174. Asia-Pacific Psychiatric API Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 175. Asia-Pacific Psychiatric API Sales by Country (2021-2026) & (k units) Table 176. Asia-Pacific Psychiatric API Sales Market Share by Country (2021-2026) Table 177. Asia-Pacific Psychiatric API Sales Forecast by Country (2027-2032) & (k units) Table 178. Asia-Pacific Psychiatric API Sales Market Share Forecast by Country (2027-2032) Table 179. Asia-Pacific Psychiatric API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 180. Asia-Pacific Psychiatric API Market Size by Country (2021-2026) & (US$ Million) Table 181. Asia-Pacific Psychiatric API Market Share by Country (2021-2026) Table 182. Asia-Pacific Psychiatric API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 183. Asia-Pacific Psychiatric API Market Share Forecast by Country (2027-2032) Table 184. Latin America Psychiatric API Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 185. Latin America Psychiatric API Sales by Country (2021-2026) & (k units) Table 186. Latin America Psychiatric API Sales Market Share by Country (2021-2026) Table 187. Latin America Psychiatric API Sales Forecast by Country (2027-2032) & (k units) Table 188. Latin America Psychiatric API Sales Market Share Forecast by Country (2027-2032) Table 189. Latin America Psychiatric API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 190. Latin America Psychiatric API Market Size by Country (2021-2026) & (US$ Million) Table 191. Latin America Psychiatric API Market Share by Country (2021-2026) Table 192. Latin America Psychiatric API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 193. Latin America Psychiatric API Market Share Forecast by Country (2027-2032) Table 194. Middle East and Africa Psychiatric API Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 195. Middle East and Africa Psychiatric API Sales by Country (2021-2026) & (k units) Table 196. Middle East and Africa Psychiatric API Sales Market Share by Country (2021-2026) Table 197. Middle East and Africa Psychiatric API Sales Forecast by Country (2027-2032) & (k units) Table 198. Middle East and Africa Psychiatric API Sales Market Share Forecast by Country (2027-2032) Table 199. Middle East and Africa Psychiatric API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 200. Middle East and Africa Psychiatric API Market Size by Country (2021-2026) & (US$ Million) Table 201. Middle East and Africa Psychiatric API Market Share by Country (2021-2026) Table 202. Middle East and Africa Psychiatric API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 203. Middle East and Africa Psychiatric API Market Share Forecast by Country (2027-2032) Table 204. Key Raw Materials Table 205. Raw Materials Key Suppliers Table 206. Psychiatric API Distributors List Table 207. Psychiatric API Customers List Table 208. Research Programs/Design for This Report Table 209. Authors List of This Report Table 210. Secondary Sources Table 211. Primary Sources List of Figures Figure 1. Psychiatric API Image Figure 2. Global Psychiatric API Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Psychiatric API Market Size (2021-2032) & (US$ Million) Figure 4. Global Psychiatric API Sales (2021-2032) & (k units) Figure 5. Venlafaxine Image Figure 6. Global Venlafaxine Sales YoY Growth (2021-2032) & (k units) Figure 7. Paroxetine Image Figure 8. Global Paroxetine Sales YoY Growth (2021-2032) & (k units) Figure 9. Duloxetine Image Figure 10. Global Duloxetine Sales YoY Growth (2021-2032) & (k units) Figure 11. Olanzapine Image Figure 12. Global Olanzapine Sales YoY Growth (2021-2032) & (k units) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 15. Global Psychiatric API Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Psychiatric API Market Share by Type 2025 VS 2032 Figure 17. North America Psychiatric API Sales Market Share in Volume by Type in 2025 Figure 18. North America Psychiatric API Sales Market Share in Value by Type in 2025 Figure 19. Europe Psychiatric API Sales Market Share in Volume by Type in 2025 Figure 20. Europe Psychiatric API Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Psychiatric API Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Psychiatric API Sales Market Share in Value by Type in 2025 Figure 23. Latin America Psychiatric API Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Psychiatric API Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Psychiatric API Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Psychiatric API Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Psychiatric API Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Generalized Anxiety Disorder Image Figure 30. Global Generalized Anxiety Disorder Sales YoY Growth (2021-2032) & (k units) Figure 31. Schizophrenia Image Figure 32. Global Schizophrenia Sales YoY Growth (2021-2032) & (k units) Figure 33. Fibromyalgia Image Figure 34. Global Fibromyalgia Sales YoY Growth (2021-2032) & (k units) Figure 35. Major Depressive Disorder Image Figure 36. Global Major Depressive Disorder Sales YoY Growth (2021-2032) & (k units) Figure 37. Others Image Figure 38. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 39. Global Psychiatric API Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global Psychiatric API Market Share by Application 2025 VS 2032 Figure 41. North America Psychiatric API Sales Market Share in Volume by Application in 2025 Figure 42. North America Psychiatric API Sales Market Share in Value by Application in 2025 Figure 43. Europe Psychiatric API Sales Market Share in Volume by Application in 2025 Figure 44. Europe Psychiatric API Sales Market Share in Value by Application in 2025 Figure 45. Asia-Pacific Psychiatric API Sales Market Share in Volume by Application in 2025 Figure 46. Asia-Pacific Psychiatric API Sales Market Share in Value by Application in 2025 Figure 47. Latin America Psychiatric API Sales Market Share in Volume by Application in 2025 Figure 48. Latin America Psychiatric API Sales Market Share in Value by Application in 2025 Figure 49. Middle East and Africa Psychiatric API Sales Market Share in Volume by Application in 2025 Figure 50. Middle East and Africa Psychiatric API Sales Market Share in Value by Application in 2025 Figure 51. North America Psychiatric API Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. North America Psychiatric API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. North America Psychiatric API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. North America Psychiatric API Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Psychiatric API Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Europe Psychiatric API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Psychiatric API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Europe Psychiatric API Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Psychiatric API Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Asia-Pacific Psychiatric API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Psychiatric API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Asia-Pacific Psychiatric API Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Psychiatric API Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 64. Latin America Psychiatric API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Psychiatric API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Latin America Psychiatric API Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Psychiatric API Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 68. Middle East and Africa Psychiatric API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Psychiatric API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 70. Middle East and Africa Psychiatric API Market Share by Country: 2021 VS 2025 VS 2032 Figure 71. Psychiatric API Value Chain Figure 72. Key Raw Materials Price Figure 73. Manufacturing Cost Structure Figure 74. Psychiatric API Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • Venlafaxine
  • Paroxetine
  • Duloxetine
  • Olanzapine
  • Others
Applications
  • Generalized Anxiety Disorder
  • Schizophrenia
  • Fibromyalgia
  • Major Depressive Disorder
  • Others
Companies covered
  • Yaopharma
  • Yangtze River Pharmaceutical
  • Sichuan Chuanda West China Pharmaceutical
  • Ren An Pharmaceutical
  • Eli Lilly
  • Kanghong Pharmaceutical
  • Pfizer
  • Huahai Pharmaceutical
  • Hengrui Pharmaceuticals
  • Herui Pharmaceutical
  • Dongting Pharmaceutical
  • Brilliant Pharmaceutical
  • Salutas Pharma
  • Germany Pharmaceutical
  • Dr.Reddy's Laboratories
  • Bora Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Psychiatric API Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Psychiatric API Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Psychiatric API Market by Type
  6. 1.3.1 Venlafaxine
  7. 1.3.2 Paroxetine
  8. 1.3.3 Duloxetine
  9. 1.3.4 Olanzapine
  10. 1.3.5 Others
  11. 1.4 Global Psychiatric API Market Size by Type
  12. 1.4.1 Global Psychiatric API Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Psychiatric API Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Psychiatric API Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Psychiatric API Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Psychiatric API Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Psychiatric API Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Psychiatric API Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Psychiatric API Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Psychiatric API Industry Trends
  2. 2.2 Psychiatric API Industry Drivers
  3. 2.3 Psychiatric API Industry Opportunities and Challenges
  4. 2.4 Psychiatric API Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Psychiatric API Revenue (2021-2026)
  2. 3.2 Global Top Players by Psychiatric API Sales (2021-2026)
  3. 3.3 Global Top Players by Psychiatric API Price (2021-2026)
  4. 3.4 Global Psychiatric API Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Psychiatric API Major Company Production Sites & Headquarters
  6. 3.6 Global Psychiatric API Company, Product Type & Application
  7. 3.7 Global Psychiatric API Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Psychiatric API Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Psychiatric API Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Psychiatric API Tier 1, Tier 2, and Tier 3
4 Psychiatric API Regional Status and Outlook
  1. 4.1 Global Psychiatric API Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Psychiatric API Historic Market Size by Region
  3. 4.2.1 Global Psychiatric API Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Psychiatric API Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Psychiatric API Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Psychiatric API Forecasted Market Size by Region
  7. 4.3.1 Global Psychiatric API Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Psychiatric API Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Psychiatric API Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Psychiatric API by Application
  1. 5.1 Psychiatric API Market by Application
  2. 5.1.1 Generalized Anxiety Disorder
  3. 5.1.2 Schizophrenia
  4. 5.1.3 Fibromyalgia
  5. 5.1.4 Major Depressive Disorder
  6. 5.1.5 Others
  7. 5.2 Global Psychiatric API Market Size by Application
  8. 5.2.1 Global Psychiatric API Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global Psychiatric API Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global Psychiatric API Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America Psychiatric API Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe Psychiatric API Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific Psychiatric API Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America Psychiatric API Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa Psychiatric API Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Yaopharma
  2. 6.1.1 Yaopharma Company Information
  3. 6.1.2 Yaopharma Business Overview
  4. 6.1.3 Yaopharma Psychiatric API Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Yaopharma Psychiatric API Product Portfolio
  6. 6.1.5 Yaopharma Recent Developments
  7. 6.2 Yangtze River Pharmaceutical
  8. 6.2.1 Yangtze River Pharmaceutical Company Information
  9. 6.2.2 Yangtze River Pharmaceutical Business Overview
  10. 6.2.3 Yangtze River Pharmaceutical Psychiatric API Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Yangtze River Pharmaceutical Psychiatric API Product Portfolio
  12. 6.2.5 Yangtze River Pharmaceutical Recent Developments
  13. 6.3 Sichuan Chuanda West China Pharmaceutical
  14. 6.3.1 Sichuan Chuanda West China Pharmaceutical Company Information
  15. 6.3.2 Sichuan Chuanda West China Pharmaceutical Business Overview
  16. 6.3.3 Sichuan Chuanda West China Pharmaceutical Psychiatric API Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Sichuan Chuanda West China Pharmaceutical Psychiatric API Product Portfolio
  18. 6.3.5 Sichuan Chuanda West China Pharmaceutical Recent Developments
  19. 6.4 Ren An Pharmaceutical
  20. 6.4.1 Ren An Pharmaceutical Company Information
  21. 6.4.2 Ren An Pharmaceutical Business Overview
  22. 6.4.3 Ren An Pharmaceutical Psychiatric API Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Ren An Pharmaceutical Psychiatric API Product Portfolio
  24. 6.4.5 Ren An Pharmaceutical Recent Developments
  25. 6.5 Eli Lilly
  26. 6.5.1 Eli Lilly Company Information
  27. 6.5.2 Eli Lilly Business Overview
  28. 6.5.3 Eli Lilly Psychiatric API Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Eli Lilly Psychiatric API Product Portfolio
  30. 6.5.5 Eli Lilly Recent Developments
  31. 6.6 Kanghong Pharmaceutical
  32. 6.6.1 Kanghong Pharmaceutical Company Information
  33. 6.6.2 Kanghong Pharmaceutical Business Overview
  34. 6.6.3 Kanghong Pharmaceutical Psychiatric API Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Kanghong Pharmaceutical Psychiatric API Product Portfolio
  36. 6.6.5 Kanghong Pharmaceutical Recent Developments
  37. 6.7 Pfizer
  38. 6.7.1 Pfizer Company Information
  39. 6.7.2 Pfizer Business Overview
  40. 6.7.3 Pfizer Psychiatric API Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Pfizer Psychiatric API Product Portfolio
  42. 6.7.5 Pfizer Recent Developments
  43. 6.8 Huahai Pharmaceutical
  44. 6.8.1 Huahai Pharmaceutical Company Information
  45. 6.8.2 Huahai Pharmaceutical Business Overview
  46. 6.8.3 Huahai Pharmaceutical Psychiatric API Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Huahai Pharmaceutical Psychiatric API Product Portfolio
  48. 6.8.5 Huahai Pharmaceutical Recent Developments
  49. 6.9 Hengrui Pharmaceuticals
  50. 6.9.1 Hengrui Pharmaceuticals Company Information
  51. 6.9.2 Hengrui Pharmaceuticals Business Overview
  52. 6.9.3 Hengrui Pharmaceuticals Psychiatric API Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Hengrui Pharmaceuticals Psychiatric API Product Portfolio
  54. 6.9.5 Hengrui Pharmaceuticals Recent Developments
  55. 6.10 Herui Pharmaceutical
  56. 6.10.1 Herui Pharmaceutical Company Information
  57. 6.10.2 Herui Pharmaceutical Business Overview
  58. 6.10.3 Herui Pharmaceutical Psychiatric API Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Herui Pharmaceutical Psychiatric API Product Portfolio
  60. 6.10.5 Herui Pharmaceutical Recent Developments
  61. 6.11 Dongting Pharmaceutical
  62. 6.11.1 Dongting Pharmaceutical Company Information
  63. 6.11.2 Dongting Pharmaceutical Business Overview
  64. 6.11.3 Dongting Pharmaceutical Psychiatric API Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Dongting Pharmaceutical Psychiatric API Product Portfolio
  66. 6.11.5 Dongting Pharmaceutical Recent Developments
  67. 6.12 Brilliant Pharmaceutical
  68. 6.12.1 Brilliant Pharmaceutical Company Information
  69. 6.12.2 Brilliant Pharmaceutical Business Overview
  70. 6.12.3 Brilliant Pharmaceutical Psychiatric API Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Brilliant Pharmaceutical Psychiatric API Product Portfolio
  72. 6.12.5 Brilliant Pharmaceutical Recent Developments
  73. 6.13 Salutas Pharma
  74. 6.13.1 Salutas Pharma Company Information
  75. 6.13.2 Salutas Pharma Business Overview
  76. 6.13.3 Salutas Pharma Psychiatric API Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Salutas Pharma Psychiatric API Product Portfolio
  78. 6.13.5 Salutas Pharma Recent Developments
  79. 6.14 Germany Pharmaceutical
  80. 6.14.1 Germany Pharmaceutical Company Information
  81. 6.14.2 Germany Pharmaceutical Business Overview
  82. 6.14.3 Germany Pharmaceutical Psychiatric API Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Germany Pharmaceutical Psychiatric API Product Portfolio
  84. 6.14.5 Germany Pharmaceutical Recent Developments
  85. 6.15 Dr.Reddy's Laboratories
  86. 6.15.1 Dr.Reddy's Laboratories Company Information
  87. 6.15.2 Dr.Reddy's Laboratories Business Overview
  88. 6.15.3 Dr.Reddy's Laboratories Psychiatric API Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Dr.Reddy's Laboratories Psychiatric API Product Portfolio
  90. 6.15.5 Dr.Reddy's Laboratories Recent Developments
  91. 6.16 Bora Pharmaceutical
  92. 6.16.1 Bora Pharmaceutical Company Information
  93. 6.16.2 Bora Pharmaceutical Business Overview
  94. 6.16.3 Bora Pharmaceutical Psychiatric API Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Bora Pharmaceutical Psychiatric API Product Portfolio
  96. 6.16.5 Bora Pharmaceutical Recent Developments
7 North America by Country
  1. 7.1 North America Psychiatric API Sales by Country
  2. 7.1.1 North America Psychiatric API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Psychiatric API Sales by Country (2021-2026)
  4. 7.1.3 North America Psychiatric API Sales Forecast by Country (2027-2032)
  5. 7.2 North America Psychiatric API Market Size by Country
  6. 7.2.1 North America Psychiatric API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Psychiatric API Market Size by Country (2021-2026)
  8. 7.2.3 North America Psychiatric API Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Psychiatric API Sales by Country
  2. 8.1.1 Europe Psychiatric API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Psychiatric API Sales by Country (2021-2026)
  4. 8.1.3 Europe Psychiatric API Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Psychiatric API Market Size by Country
  6. 8.2.1 Europe Psychiatric API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Psychiatric API Market Size by Country (2021-2026)
  8. 8.2.3 Europe Psychiatric API Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Psychiatric API Sales by Country
  2. 9.1.1 Asia-Pacific Psychiatric API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Psychiatric API Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Psychiatric API Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Psychiatric API Market Size by Country
  6. 9.2.1 Asia-Pacific Psychiatric API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Psychiatric API Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Psychiatric API Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Psychiatric API Sales by Country
  2. 10.1.1 South America Psychiatric API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Psychiatric API Sales by Country (2021-2026)
  4. 10.1.3 South America Psychiatric API Sales Forecast by Country (2027-2032)
  5. 10.2 South America Psychiatric API Market Size by Country
  6. 10.2.1 South America Psychiatric API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Psychiatric API Market Size by Country (2021-2026)
  8. 10.2.3 South America Psychiatric API Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Psychiatric API Sales by Country
  2. 11.1.1 Middle East and Africa Psychiatric API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Psychiatric API Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Psychiatric API Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Psychiatric API Market Size by Country
  6. 11.2.1 Middle East and Africa Psychiatric API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Psychiatric API Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Psychiatric API Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Psychiatric API Value Chain Analysis
  2. 12.1.1 Psychiatric API Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Psychiatric API Production Mode & Process
  7. 12.2 Psychiatric API Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Psychiatric API Distributors
  10. 12.2.3 Psychiatric API Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst